Yahoo · Oct 20, 2026
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
Sector ETF report for PRN
NASDAQ · PRN
Financial Services · Asset Management
$192.35
Up+$1.89 (+0.99%)
Updated Nov 11, 2026, 11:42 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PRN
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 10, 2026
PRN closed at $192.35 after 21 trading sessions, down 3.15% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | $190.41 | $192.45 | $190.0675 | $192.35 | 20.44K |
| Nov 9, 2026 | $186.58 | $191.27 | $186.58 | $190.4568 | 22.77K |
| Nov 6, 2026 | $184.41 | $185.06 | $182.75 | $184.54 | 19.4K |
| Nov 5, 2026 | $192.29 | $192.40 | $183.53 | $183.585 | 37.56K |
| Nov 4, 2026 | $196.70 | $196.70 | $191.71 | $192.8054 | 25.34K |
| Nov 3, 2026 | $194.92 | $197.205 | $194.92 | $195.6526 | 13.83K |
| Nov 2, 2026 | $194.53 | $196.895 | $194.5157 | $194.5157 | 13.05K |
| Oct 30, 2026 | $196.21 | $196.21 | $192.6601 | $193.4876 | 6.76K |
| Oct 29, 2026 | $195.96 | $197.1249 | $195.9401 | $196.7608 | 3.26K |
| Oct 28, 2026 | $195.88 | $196.785 | $195.065 | $195.76 | 8.95K |
| Oct 27, 2026 | $196.87 | $196.87 | $195.23 | $195.5399 | 6.37K |
| Oct 26, 2026 | $194.31 | $196.525 | $194.31 | $196.1831 | 4.72K |
| Oct 23, 2026 | $191.93 | $193.87 | $191.78 | $193.4056 | 80.22K |
| Oct 22, 2026 | $193.225 | $193.225 | $190.31 | $192.1153 | 23.28K |
| Oct 21, 2026 | $193.97 | $194.99 | $193.82 | $194.9073 | 19.33K |
| Oct 20, 2026 | $192.06 | $193.28 | $191.38 | $192.4819 | 14.46K |
| Oct 19, 2026 | $193.25 | $194.0828 | $192.19 | $192.3218 | 8.3K |
| Oct 16, 2026 | $195.66 | $196.63 | $192.4901 | $193.12 | 6.35K |
| Oct 15, 2026 | $194.40 | $195.34 | $192.58 | $195.1753 | 19.17K |
| Oct 14, 2026 | $197.155 | $197.25 | $194.89 | $195.6491 | 6.86K |
| Oct 13, 2026 | $197.79 | $198.69 | $196.25 | $198.6085 | 13.7K |
The latest Smart Investors Daily articles mentioning PRN.
Company
Market Activity
Research & News
PRN research
Company profile and research snapshot.
PRN changed its tune in February 2014 but continues to provide an alternate take on US industrial firms. The old version of the fund used a multi-factor selection method coupled with a tiered equal-weighting scheme that produced a vastly different portfolio than our neutral benchmark. Currently the fund follows a Dorsey-Wright relative strength index that selects and weights stocks by price momentum. The fund selects the top, at least 30 stocks, with the highest momentum scores in the industrial space. The fund uses a full replication indexing strategy, meaning PRN will generally invest in all of the stocks of the underlying index and in proportion to the weightings. Overall, PRN offers a different, growth-focused take on industrial stocks. Investors should consider all-in costs of holding the fund. The fund is reconstituted and rebalanced quarterly. Prior to August 28, 2023, the ETF's name was Invesco DWA Industrials Momentum ETF.
Consensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Oct 20, 2026
Sector ETF report for PRN
SeekingAlpha · Oct 2, 2026
AI data center construction drives an industrial boom through 2027. Explore PRN & AIRR ETFs for diversified exposureâplus key risks and valuations.
Yahoo · Sep 3, 2026
TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, announced today that management will participate in the Lake Street Capital Markets “BIG10” Conference on September 10, 2026 in New York City. The event will consist of one-on-one investor meetings. Due to the format of the event, no webcast will be available. A
Yahoo · Sep 1, 2026
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the appointment of Richard Fabian as its new President, effective immediately. Mr. Fabian succeeds Mathieu Burtnyk, PhD, who has shifted to the newly created position of Chief Technology Officer. Mr. Fabian has an accomplished history of sales, m
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PRN.